Vyne Therapeutics (VYNE) has had the highest return since September 30, 2025 by a US stock, returning 801,215.8%.
| ASSET | % RETURN |
|---|---|
Vyne Therapeutics (VYNE) | 801,215.79% |
WhiteHawk Minerals (WHK) | 436,733.33% |
Aptorum Group Ltd Class A (APM) | 420,400% |
Seaport Therapeutics, Inc Common Stock (SPTX) | 239,600% |
SharonAI Holdings, Inc Class A Common Stock (SHAZ) | 138,569.35% |
Mega Fortune Company Limited Ordinary Shares (MGRT) | 2,046.41% |
CBL International Limited Ordinary Shares (BANL) | 1,672.86% |
AXT (AXTI) | 1,576.37% |
Sandisk (SNDK) | 1,324.87% |
Trinity Biotech (TRIB) | 1,109.14% |
Climb Bio (CLYM) | 773.87% |
Erasca (ERAS) | 766.03% |
Damora Therapeutics (DMRA) | 764.13% |
Alto Neuroscience (ANRO) | 753.25% |
Sellas Life Sciences (SLS) | 739.74% |
Q32 Bio (QTTB) | 688.14% |
Adlai Nortye Ltd American Depositary Shares (ANL) | 686.67% |
Praxis Precision Medicines (PRAX) | 616.61% |
Spyre Therapeutics (SYRE) | 560.26% |
Charming Medical Limited Class A Ordinary Shares (MCTA) | 539.54% |
Alumis (ALMS) | 536.32% |
Oruka Therapeutics (ORKA) | 493.6% |
Micron Technology (MU) | 474.17% |
Immix Biopharma (IMMX) | 473.3% |
Talkspace (TALK) | 458.18% |